参考文献

[1]National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology:Uterine Neoplasms,[EB/OL].http://www.ascopost.com/issues/maj-25-2017/nccn-clinical-practice-guidelines-in-oncology-nccn-guidelines-2017-guidelines/.[2017-05-25].

[2]Kurman R J,Carcangiu M L,Herrington S,et al.WHO Classification of Tumours of Female Reproductive Organs.IARC:Lyon 2014.

[3]Berek J S.Berek & Novak’s Gynecology[M].15th ed.Philadelphia:Lippincott Williams & Wilkins,2012.(https://www.daowen.com)

[4]沈铿，马丁.妇产科学[M].3版.北京：人民卫生出版社，2015.

[5]Blecharz P.Reinfuss M.Jakubowicz J,et al.Prognostic factors in patient with primary invasive vaginal carcinoma[J].Ginekol Pol,2012,83(12):904-909.

[6]Rajagopalan M S,Xu K M,Lin J F,et al.Adoption and impact of concurrent chemoradiation therapy for vaginal cancer:a National Cancer Data Bass(NCDB)study[J].Gynecol Oncol,2014,135(3):495-502.